Cite
HARVARD Citation
Rahaghi, F. et al. (2022). Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat. Pulmonary circulation. p. n/a. [Online].